Flurandrenolide: uses, dosing, side effects & brands
Flurandrenolide is a corticosteroid sold in the U.S. under 3 brand and generic names, for facial dermatoses, foot dermatoses and hand dermatoses. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Drug class
- Corticosteroid
- Treats (across its forms)
- Facial Dermatoses, Foot Dermatoses and Hand Dermatoses
- Available as
- Topical · Tape
- Sold as
- 3 products — Cordran, Cordran Sp and Flurandrenolide
- Prescription?
- Prescription only
- Generic available?
- Yes
- What the pharmacy pays
- about $1 per ml — not your price
Get treated for Flurandrenolide conditions online
Licensed online providers — consult & get prescribed if eligible.
Advertising disclosure: We may earn a commission, at no extra cost to you. This never affects our ratings. Details
How flurandrenolide is dosed
From the FDA label for Cordran (application NDA016455). Other flurandrenolide products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of Cordran Tape and other occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted. Replacement of the tape every 12 hours produces the lowest incidence of adverse reactions, but it may be left in place for 24 hours if it is well tolerated and adheres satisfactorily. When necessary, the tape may be used at night only and removed during the day. If ends of the tape loosen prematurely, they may be trimmed off and replaced with fresh tape. The directions given below are included for the patient to follow unless otherwise instructed by the physician.
Flurandrenolide side effects
The following local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis. The following may occur more frequently with occlusive dressings: maceration of the skin, secondary infection, skin atrophy, striae, miliaria.
Who shouldn’t take flurandrenolide
Topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of the components of these preparations. Use of Cordran Tape is not recommended for lesions exuding serum or in intertriginous areas.
Every flurandrenolide product we track (3)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Topical | Generic | $1 | View → | |
| 2 | Not yet rated | Prescription | Topical | Generic | $1 | View → | |
| 3 | Not yet rated | Prescription | Topical | Generic | $1 | View → |
Combination products containing flurandrenolide
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
How long flurandrenolide keeps
No flurandrenolide label we read sets a separate limit for after opening, but they do specify how it must be stored — and the stability behind any date assumes those conditions.
Does flurandrenolide expire? The in-use limits and storage rules from its labelsFlurandrenolide and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for flurandrenolide: levels in milk, effects in breastfed infants, and the drugs it would consider insteadFlurandrenolide has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breastfed infant by passage into breastmilk. However, it would be prudent to use the least potent drug on the smallest area of skin possible. It is particularly important to ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only the lower potency corticosteroids should be used on the nipple or areola where the infant could directly ingest the drugs from the skin. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking. Any topical corticosteroid should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.
National Institute of Child Health and Human Development, record revised January 18, 2021. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about flurandrenolide
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 86 reports naming flurandrenolide, and the FDA flagged 71% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- pruritus12 reports
- night sweats8 reports
- headache6 reports
- swelling face5 reports
- epilepsy4 reports
- hypersensitivity4 reports
- asthenia3 reports
- blister3 reports
Read these as a signal, not a rate. A report does not mean flurandrenolide caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved August 25, 2026.
Related calculators
Frequently asked questions
What is flurandrenolide?
Cordran (Flurandrenolide) is a corticosteroid used to treat Facial Dermatoses, Foot Dermatoses, Hand Dermatoses, Inflammation.
What kind of drug is flurandrenolide?
The FDA classifies flurandrenolide as a corticosteroid. Corticosteroids mimic the body's natural stress hormone cortisol: they enter cells and bind a glucocorticoid receptor that switches off genes for inflammatory chemicals, calming swelling, redness, and an overactive immune response. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.
Can you take flurandrenolide with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run flurandrenolide against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is flurandrenolide sold under?
We track 3 flurandrenolide-containing products in the U.S.: Cordran, Cordran Sp and Flurandrenolide. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does flurandrenolide come in?
Across the brands we track, flurandrenolide is currently marketed as topical and tape, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic flurandrenolide?
Yes. Our catalog lists 1 generic flurandrenolide product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.
Cite this page
- APA
- pharmaranks. (2026, July 24). Flurandrenolide: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/flurandrenolide
- MLA
- “Flurandrenolide: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/flurandrenolide.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for flurandrenolide on DailyMed (NIH) ↗.